Onyx to initiate phase III trial with ONYX-015 in treatment of head and neck cancer Sep. 8, 1999 No Comments
Antiproliferative agents and protein farnesyltransferase inhibitors designed at RPR Sep. 8, 1999 No Comments
Schering-Plough and British Biotech to develop MMPIs for treatment of cancer Sep. 7, 1999 No Comments